On September 30, 2026, StoneX started coverage of Alto Ingredients Inc (ALTO) at Buy.
One of one firm active in the past 90 days rates the stock in the bullish tier. As of October 30, 2026, five analysts place the consensus mean at $8.50, the median at $8.16 and the range at $7.07 to $10.50.
The Q4 FY2026 consensus calls for $0.08 in EPS on $258.25 million in revenue. The next earnings date is March 2, 2027.
